Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy and Body Weight in Adults with Overweight or Obesity

Rayner, C.K.Jones, K.L.Horowitz, M.2025-07-112025-07-112021Journal of the American Medical Association (JAMA), 2021; 326(12):1213-12140098-74841538-3598https://hdl.handle.net/2440/145877Comment and ResponseAbstract unavailable.en© 2021, American Medical AssociationCommentry; Reponse; Semaglutide vs Placebo; weight loss; semaglutide; glucagon-like peptide 1 receptor agonist (GLP-1RA)HumansObesityBehavior TherapyAdultOverweightGlucagon-Like PeptidesSemaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy and Body Weight in Adults with Overweight or ObesityJournal article10.1001/jama.2021.130212024-05-06589513Rayner, C.K. [0000-0002-5527-256X]Jones, K.L. [0000-0002-1155-5816]Horowitz, M. [0000-0002-0942-0306]